Cytokinetics, Inc. (CYTK)
74.84
0.00 (0.00%)
USD |
NASDAQ |
May 07, 12:02
Cytokinetics SG&A Expense (TTM) : 226.90M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Bristol Myers Squibb Co. | 7.30B |
| Johnson & Johnson | 24.60B |
| Regeneron Pharmaceuticals, Inc. | 2.715B |
| Edgewise Therapeutics, Inc. | 40.02M |
| Moderna, Inc. | 979.00M |